BACKGROUND: Breast cancer risk increases during pregnancy and remains elevated for a number of years thereafter. Cancer-associated proteins that are secreted into breast milk may provide a means to detect cancer in the lactating breast or to assess future breast cancer risk. OBJECTIVE: To determine whether proteins linked to breast cancer would be differentially expressed in matched (both breasts from each participant) human milk samples collected from women with unilateral breast cancer. METHODS: Five cancer-associated proteins (basic fibroblast growth factor [bFGF], YKL-40, neutrophil gelatinase-associated lipocalin, and transforming growth factor β1 and β2) were analyzed in milk provided by 5 lactating women, 4 of whom were known to have cancer in 1 breast (and the opposite breast clinically disease free) at the time of milk collection and 1 who developed breast cancer 2 years after milk collection. RESULTS: Expression was significantly higher for TGFβ2 (P = .03) and bFGF (P =.03) in the breasts with cancer. CONCLUSION: These proteins may play a role in assessing a woman's risk of pregnancy-associated breast cancer. Because of variable protein concentration among patients and the limited sample size, the results are considered preliminary.
BACKGROUND:Breast cancer risk increases during pregnancy and remains elevated for a number of years thereafter. Cancer-associated proteins that are secreted into breast milk may provide a means to detect cancer in the lactating breast or to assess future breast cancer risk. OBJECTIVE: To determine whether proteins linked to breast cancer would be differentially expressed in matched (both breasts from each participant) human milk samples collected from women with unilateral breast cancer. METHODS: Five cancer-associated proteins (basic fibroblast growth factor [bFGF], YKL-40, neutrophil gelatinase-associated lipocalin, and transforming growth factor β1 and β2) were analyzed in milk provided by 5 lactating women, 4 of whom were known to have cancer in 1 breast (and the opposite breast clinically disease free) at the time of milk collection and 1 who developed breast cancer 2 years after milk collection. RESULTS: Expression was significantly higher for TGFβ2 (P = .03) and bFGF (P =.03) in the breasts with cancer. CONCLUSION: These proteins may play a role in assessing a woman's risk of pregnancy-associated breast cancer. Because of variable protein concentration among patients and the limited sample size, the results are considered preliminary.
Authors: Ana Sahores; Virginia Figueroa; María May; Marcos Liguori; Adrián Rubstein; Cynthia Fuentes; Britta M Jacobsen; Andrés Elía; Paola Rojas; Gonzalo R Sequeira; Michelle M Álvarez; Pedro González; Hugo Gass; Stephen Hewitt; Alfredo Molinolo; Claudia Lanari; Caroline A Lamb Journal: Horm Cancer Date: 2018-06-28 Impact factor: 3.869
Authors: Bo Zhao; Jingjing Gao; Mahalia A C Serrano; Kathleen F Arcaro; S Thayumanavan; Richard W Vachet Journal: Anal Bioanal Chem Date: 2020-01-10 Impact factor: 4.142
Authors: Lynn S Chollet-Hinton; Alison M Stuebe; Patricia Casbas-Hernandez; Ellen Chetwynd; Melissa A Troester Journal: Breastfeed Med Date: 2014-12 Impact factor: 1.817
Authors: Hannah P Yang; Sallie Smith Schneider; Christina M Chisholm; Eva P Browne; Sidra Mahmood; Gretchen L Gierach; Sarah Lenington; Douglas L Anderton; Mark E Sherman; Kathleen F Arcaro Journal: Cancer Causes Control Date: 2015-01-21 Impact factor: 2.506
Authors: Jeanne Murphy; Ruth M Pfeiffer; Brittny C Davis Lynn; Ana I Caballero; Eva P Browne; Elizabeth C Punska; Hannah P Yang; Roni T Falk; Douglas L Anderton; Gretchen L Gierach; Kathleen F Arcaro; Mark E Sherman Journal: Breast Cancer Res Treat Date: 2018-08-06 Impact factor: 4.872